BRIEF-Adocia and Lilly initiate new study of BioChaperone Lispro
August 27, 2015 at 01:59 AM EDT
* Adocia and Eli Lilly initiate new PHASE 1B study of repeated administration of Ultra-Rapid BioChaperone Lispro in patients with type 1 diabetes
